LivaNova PLC Unrealized Gain (Loss) on Derivatives
LivaNova PLC (LIVN) reported Unrealized Gain (Loss) on Derivatives of -$52.21 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnDerivatives · last filed 2026-08-05
- LivaNova PLC unrealized gain (loss) on derivatives for the quarter ending 2026-06-30 was -$42.42M, a 596.52% decline year-over-year.
- LivaNova PLC unrealized gain (loss) on derivatives for the quarter ending 2026-03-31 was -$9.79M, a 152.33% decline year-over-year.
- LivaNova PLC unrealized gain (loss) on derivatives for the quarter ending 2025-12-31 was -$10.09M, a 139.20% decline year-over-year.
- LivaNova PLC unrealized gain (loss) on derivatives for the quarter ending 2025-09-30 was -$10.27M, a 185.12% decline year-over-year.
- LivaNova PLC unrealized gain (loss) on derivatives for fiscal 2025 was $6.90M, a 72.78% decline from fiscal 2024.
- LivaNova PLC unrealized gain (loss) on derivatives for fiscal 2024 was $25.34M, a 10.62% increase from fiscal 2023.
- LivaNova PLC unrealized gain (loss) on derivatives for fiscal 2023 was $22.91M, a 40.73% decline from fiscal 2022.
- LivaNova PLC unrealized gain (loss) on derivatives for fiscal 2022 was $38.66M.
| Period end | Unrealized Gain (Loss) on Derivatives 3 month | Unrealized Gain (Loss) on Derivatives 6 month | Unrealized Gain (Loss) on Derivatives 9 month | Unrealized Gain (Loss) on Derivatives 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$42.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$52.21M 10-Q · filed 2026-08-05 | -$62.30M derived: sum of 3 quarters · filed 2026-08-05 | -$72.57M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$9.79M 10-Q · filed 2026-05-06 | -$19.89M derived: sum of 2 quarters · filed 2026-05-06 | -$30.16M derived: sum of 3 quarters · filed 2026-05-06 | -$21.61M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$10.09M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$20.36M derived: sum of 2 quarters · filed 2026-02-25 | -$11.82M derived: sum of 3 quarters · filed 2026-08-05 | $6.90M 10-K · filed 2026-02-25 |
| 2025-09-30 | -$10.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$1.73M derived: sum of 2 quarters · filed 2026-08-05 | $16.99M 10-Q · filed 2025-11-05 | $42.73M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $8.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $27.26M 10-Q · filed 2026-08-05 | $53.01M derived: sum of 3 quarters · filed 2026-08-05 | $65.07M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $18.72M 10-Q · filed 2026-05-06 | $44.46M derived: sum of 2 quarters · filed 2026-05-06 | $56.53M derived: sum of 3 quarters · filed 2026-05-06 | $55.66M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $25.75M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $37.81M derived: sum of 2 quarters · filed 2026-02-25 | $36.94M derived: sum of 3 quarters · filed 2026-02-25 | $25.34M 10-K · filed 2026-02-25 |
| 2024-09-30 | $12.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $11.20M derived: sum of 2 quarters · filed 2025-11-05 | -$400.00K 10-Q · filed 2025-11-05 | |
| 2024-06-30 | -$867.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$12.46M 10-Q · filed 2025-08-06 | ||
| 2024-03-31 | -$11.60M 10-Q · filed 2025-05-07 | |||
| 2023-12-31 | $22.91M 10-K · filed 2026-02-25 | |||
| 2022-12-31 | $38.66M 10-K · filed 2025-02-25 | |||
| 2021-12-31 | -$17.62M 10-K · filed 2024-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |